A groundbreaking research facility which will study the medical benefits of cannabis is set to be unveiled this summer.
MediPen, which launched a cannabis-based “vaporiser” last year, says it will run a “strenuous” course of clinical trials into the medicinal applications of cannabis from its 1,800sq ft site in Cardiff.
The company says it will work with industry-leading scientists and product designers at its “state-of-the-art” testing facilities in Caxton Place, Pontprennau.
A spokesman said: “With the launch of their dedicated cannabis research facility, MediPen Ltd are excited to further propel the UK to the forefront of global cannabinoid research and innovation.”
One of its first studies will involve looking at a cannabis-based product which aims to reduce the negative effects of chemotherapy such as nausea and vomiting.
It is now the second UK company